查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物活性傷口敷料市場——增長、趨勢和預測 (2023-2028)
市場調查報告書
商品編碼
1190055

生物活性傷口敷料市場——增長、趨勢和預測 (2023-2028)

Bioactive Wound Dressing Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，生物活性傷口敷料市場預計將以 11% 的複合年增長率增長。

COVID-19 大流行影響了生物活性傷口敷料市場和整個醫療保健行業，由於世界各國政府實施的社會疏遠措施，醫院和醫療服務都在萎縮。 COVID-19 大流行影響了全球經濟，並顯著影響了世界各地醫院對非 COVID-19 患者的綜合醫院護理能力。 Uptodate Co., Ltd. 發表的一篇於 2022 年 6 月更新的論文指出，在 COVID-19 大流行期間，本應被視為基本護理的傷口護理的提供發生了變化。 在大流行期間，重點是傷口護理，以盡量減少住院和手術並防止嚴重的傷口並發症，而不是傷口的完全癒合。 可用生物活性傷口敷料服務的減少受到 COVID-19 大流行的負面影響，但在過去兩年中已經恢復並實現強勁增長。

生物活性傷口敷料市場受到技術進步、人口老齡化、慢性傷口負擔增加以及與傳統傷口癒合治療相關的挑戰的推動。 2021 年 3 月發表在《傷口護理進展雜誌》上的一篇論文發現，慢性傷口會影響大約 2.5% 的美國人口的生活質量 (QoL)，這使得傷口護理管理對美國醫療保健部門至關重要。有人指出，它具有顯著的經濟影響。 慢性傷口在老年人群中最為常見。 隨著美國人口老齡化的加劇，慢性傷口的發生率預計會增加，這也將推動所研究市場的增長。 根據世界銀行 2022 年報告，歐盟的外科手術數量（每 100,000 人）為 11,075 次。 歐洲手術數量的增加直接促進了長期研究市場的增長，因為手術疤痕也在增加。 因此，隨著手術數量的增加，預計在預測期內所研究的市場將增長。

然而，不斷上漲的治療成本和不利的報銷政策是阻礙生物活性傷口敷料市場增長的一些因素。

生物活性傷口敷料市場的趨勢

預計在預測期內市場細分將佔據很大份額

各種外傷和燒傷的發病率不斷增加是推動採用傷口敷料的主要因素之一。 根據 2021 年 10 月發表的《外科研究雜誌》的數據，非洲記錄在案的燒傷總數為 44,369 人，其中男性的平均比例為 56%。 燒傷 (61%) 是最常見的傷害原因，其次是明火 (17%)。 同樣，世衛組織 2022 年 1 月發布的數據表明，至少 33 個非洲、南美洲和西太平洋熱帶、亞熱帶和溫帶氣候國家報告了布魯裡潰瘍。 布魯裡潰瘍的鑑別診斷包括熱帶噬菌體潰瘍和由於動靜脈功能不全引起的慢性腿部潰瘍。 35% 的上肢、55% 的下肢和 10% 的其他部位發生這種疾病引起的病變。 有了這樣的統計數據，傷口行業有望在不久的將來見證顯著的增長。

此外，市場增長的因素之一是市場上的主要公司正在加緊努力以增加其存在。 例如，2022 年 1 月，Triad Life Sciences Inc. 簽訂了最終協議，將被 Convatec Group PLC 收購，以解決外科、慢性和燒傷傷口未滿足的臨床需求。

因此，由於上述因素，預計該細分市場在預測期內將出現顯著增長。

北美預計在預測期內實現健康增長

北美生物活性傷口敷料市場預計將在全球佔據重要的市場份額。 推動該地區市場的主要因素是適應快速老齡化社會的先進醫療體系、高糖尿病人口和創新。 糖尿病的患病率近年來有所增加，許多報告預測未來還會進一步增加。 例如，根據國際糖尿病聯合會第 10 版糖尿病地圖集，2021 年美國約有 3220 萬人患有糖尿病，預計到 2045 年這一數字將上升到 3630 萬。 根據加拿大糖尿病協會 (CDA) 的數據，到 2021 年，加拿大將有大約 1150 萬人被診斷出患有糖尿病。 截至 2021 年，估計約有 29% 的加拿大人口易患糖尿病，包括確診病例和未確診病例。 隨著日本糖尿病患者數量的增加，預計糖尿病潰瘍患者的數量也會增加。 同樣，《足部雜誌》2022 年 2 月的一篇文章指出，美國近 67% 的下肢截肢與糖尿病有關。 該國大量糖尿病足潰瘍病例可能會推動市場增長。 因此，預計該行業在預測期內將出現顯著增長。

生物活性傷口敷料市場的競爭分析

生物活性傷口敷料市場較為分散且競爭激烈。 主要市場參與者包括 3M、Convatec Group PLC、Monlnlycke Health Care AB、Smith & Nephew PLC、B. Braun SE。 此外，公司專注於行業合作、合併、收購和合作夥伴關係，以增加他們在所研究市場中的影響力。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 增加慢性傷口和相關疾病的負擔
    • 生物活性傷口敷料的進展
  • 市場製約因素
    • 缺乏適當的報銷
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品分類
    • 水膠體
    • 藻酸鹽敷料
    • 皮膚替代品
    • 抗菌敷料
    • 其他產品
  • 通過使用
    • 傷口
    • 伯恩斯
    • 潰瘍
    • 其他用途
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • 3M
    • B. Braun SE
    • BSN Medical（Essity）
    • Convatec Group PLC
    • Covalon Technologies Ltd
    • DermaRite Industries LLC
    • Hollister Incorporated
    • Integra LifeSciences Holdings Corporation
    • Johnson & Johnson
    • Medtronic PLC
    • Monlnlycke Health Care AB
    • Smith & Nephew PLC

第7章 市場機會今後動向

簡介目錄
Product Code: 69586

The bioactive wound dressing market is expected to register a CAGR of 11% during the forecast period.

The COVID-19 outbreak impacted the bioactive wound dressing market and the overall healthcare sector, as hospitals and healthcare services were reduced due to social distancing measures taken by governments worldwide. The COVID-19 pandemic affected the global economy and greatly impacted the functioning of general hospital care for non-COVID-19 patients in hospitals globally. The article presented by UpToDate Inc., updated in June 2022, indicated that the delivery of wound care, which should be regarded as an essential medical service, shifted during the COVID-19 pandemic. During the pandemic, significant importance was placed on wound care to prevent serious wound complications by minimizing hospitalization and surgery rather than completing wound healing. The reduction in the available bioactive wound dressing services was adversely impacted by the COVID-19 pandemic but has recovered in the two years to post strong growth.

The bioactive wound dressing market is driven by advancements in technology, the growing aging population, the rising burden of chronic wounds, and problems associated with conventional wound healing procedures. An article published in the Journal of Advances in Wound Care in March 2021 indicated that chronic wounds impact the quality of life (QoL) of nearly 2.5% of the US population and that wound care management has an important economic impact on the US healthcare sector. Chronic wounds are most commonly seen in the elderly population of the nation. With the growing geriatric population in United States, the incidence of chronic wounds is expected to increase, thereby aiding the growth of the market studied. According to the World Bank Report 2022, there were 11,075 surgical procedures (per 100,000 population) in the European Union. The rising number of surgeries in Europe has been directly contributing to the growth of the market studied in the long run, as wounds have also been increasing due to surgeries. Therefore, with the rising volume of surgical procedures, the market studied is expected to grow over the forecast period.

However, the high cost of treatment and unfavorable reimbursement policies are a few factors hindering the growth of the bioactive wound dressing market.

Bioactive Wound Dressing Market Trends

Wounds Segment is Expected to Hold a Significant Market Share over the Forecast Period

The increasing cases of different traumatic wounds and burns are one of the major factors driving the adoption of wound dressing. According to the Journal of Surgical Research data published in October 2021, the total number of burn patients recorded was 44,369 in Africa, of which the mean proportion of males was 56%. The most common cause of injury was scalding (61%), followed by open flame (17%). Similarly, WHO data published in January 2022 stated that at least 33 countries with tropical, subtropical, and temperate climates had reported Buruli ulcers in Africa, South America, and Western Pacific regions. Differential diagnoses of Buruli ulcers include tropical phagedenic ulcers and chronic lower leg ulcers due to arterial and venous insufficiency. The lesions due to this disease occur 35% on the upper limbs, 55% on the lower limbs, and 10% on other parts of the body. Such statistics indicate that the wounds segment is expected to witness notable growth in the near future.

Moreover, rising initiatives by key players in the market to grow their presence is another factor in the market's growth. For instance, in January 2022, Triad Life Sciences Inc. entered into a formal agreement to be acquired by Convatec Group PLC to address unmet clinical requirements in surgical wounds, chronic wounds, and burns.

Hence, owing to the aforementioned factors, the segment is expected to witness significant growth over the forecast period.

North America is Expected to Witness Healthy Growth over the Forecast Period

The North American bioactive wound dressing market is projected to have a significant market share worldwide. The major factors driving the market in the region are the rapidly growing aging population, the high diabetic population, and the developed healthcare system, which adapts to novel innovations.​ The prevalence of diabetes has increased in recent years, and many reports have predicted this prevalence to increase further in the future. For instance, according to the International Diabetes Federation Diabetes Atlas Tenth edition, in 2021, around 32.2 million people in United States had diabetes, and this is projected to grow to 36.3 million by 2045. As per the Canadian Diabetes Association (CDA), in 2021, there were around 11.5 million people in Canada diagnosed with diabetes.​ As of 2021, around 29% of the Canadian population was estimated to be susceptible to diabetes, which included both diagnosed and undiagnosed cases. The rising number of diabetic cases in the nation is expected to increase the number of diabetic ulcer cases. Similarly, an article published in the Journal of Foot in February 2022 indicated that nearly 67% of leg amputations in United States are associated with diabetes. Many cases of diabetic foot ulcers in the nation are likely to propel the market's growth. Thus, owing to the aforementioned factors, the segment is expected to show significant growth over the forecast period.

Bioactive Wound Dressing Market Competitive Analysis

The bioactive wound dressing market is moderately fragmented and competitive. The key market players include 3M, Convatec Group PLC, Monlnlycke Health Care AB, Smith & Nephew PLC, and B. Braun SE, among others. Furthermore, companies focus on industry collaborations, mergers, acquisitions, and partnerships to enhance their presence in the market studied.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Wounds and Associated Diseases
    • 4.2.2 Advancements in Bioactive Wound Dressings
  • 4.3 Market Restraints
    • 4.3.1 Lack of Proper Reimbursement
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Hydrocolloids
    • 5.1.2 Alginate Dressing
    • 5.1.3 Skin Substitutes
    • 5.1.4 Antimicrobial Dressing
    • 5.1.5 Other Products
  • 5.2 By Application
    • 5.2.1 Wounds
    • 5.2.2 Burns
    • 5.2.3 Ulcers
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 B. Braun SE
    • 6.1.3 BSN Medical (Essity)
    • 6.1.4 Convatec Group PLC
    • 6.1.5 Covalon Technologies Ltd
    • 6.1.6 DermaRite Industries LLC
    • 6.1.7 Hollister Incorporated
    • 6.1.8 Integra LifeSciences Holdings Corporation
    • 6.1.9 Johnson & Johnson
    • 6.1.10 Medtronic PLC
    • 6.1.11 Monlnlycke Health Care AB
    • 6.1.12 Smith & Nephew PLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS